您的位置: 首页 > 农业专利 > 详情页

Tuberous sclerosis treatment
专利权人:
NOVARTIS AG
发明人:
WILLIAM, BERG,JOHN, BENEDETTO,INGRID, ELMROTH,HEIDI, LANE,DAVID, LEBWOHL,WILLIAM, SELLERS,MICHAEL, STUMM
申请号:
TR201807065
公开号:
TR201807065T4
申请日:
2007.01.31
申请国别(地区):
TR
年份:
2018
代理人:
摘要:
The application, which is related to, treats and prevents neural skin barrier, the neural skin barrier such as mediated by Tuberous Sclerosis Complex (TSC), such as the method for tuberous sclerosis and the tuberous sclerosis such as mediated by 1 type neurofibromatosis.Neural skin barrier used herein includes the obstacle mediated by Tuberous Sclerosis Complex (TSC), such as tuberous sclerosis and associated disorders and 1 type neurofibromatosis and associated disorders.Present invention also provides the rapamycin derivative for treating neural skin barrier.Nörokütan bozuklukların tedavisinde kullanım için rapamisin türevleri.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充